Shares of HCA Holdings, Inc. (NYSE:HCA) have been given an average recommendation of “Buy” by the nineteen brokerages that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and twelve have issued a buy recommendation on the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $92.60.

Several equities research analysts recently commented on the stock. KeyCorp reiterated a “buy” rating and set a $95.00 target price on shares of HCA Holdings in a research report on Thursday, September 7th. ValuEngine downgraded shares of HCA Holdings from a “buy” rating to a “hold” rating in a research report on Thursday, September 7th. Cantor Fitzgerald reiterated a “buy” rating and set a $95.00 target price on shares of HCA Holdings in a research report on Wednesday, September 6th. Robert W. Baird cut their target price on shares of HCA Holdings from $95.00 to $93.00 and set an “outperform” rating on the stock in a research report on Tuesday, August 22nd. Finally, Morgan Stanley cut their target price on shares of HCA Holdings from $88.00 to $85.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 17th.

TRADEMARK VIOLATION NOTICE: “HCA Holdings, Inc. (HCA) Receives Average Recommendation of “Buy” from Brokerages” was reported by Daily Political and is owned by of Daily Political. If you are reading this piece on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The original version of this piece can be accessed at https://www.dailypolitical.com/2017/09/14/hca-holdings-inc-hca-receives-average-recommendation-of-buy-from-brokerages.html.

In related news, insider Michael S. Cuffe sold 2,150 shares of the business’s stock in a transaction on Monday, July 17th. The shares were sold at an average price of $86.44, for a total transaction of $185,846.00. Following the transaction, the insider now owns 12,363 shares in the company, valued at approximately $1,068,657.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jonathan B. Perlin sold 71,063 shares of the business’s stock in a transaction on Thursday, June 22nd. The shares were sold at an average price of $86.00, for a total transaction of $6,111,418.00. The disclosure for this sale can be found here. Insiders have sold a total of 75,363 shares of company stock worth $6,469,006 in the last quarter. 2.90% of the stock is owned by corporate insiders.

A number of hedge funds have recently made changes to their positions in HCA. Northwestern Mutual Wealth Management Co. increased its stake in HCA Holdings by 14.0% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after purchasing an additional 143 shares in the last quarter. Bronfman E.L. Rothschild L.P. increased its stake in HCA Holdings by 35.1% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock valued at $107,000 after purchasing an additional 320 shares in the last quarter. Atlantic Trust LLC bought a new stake in HCA Holdings during the 2nd quarter valued at $118,000. Lee Financial Co bought a new stake in HCA Holdings during the 2nd quarter valued at $125,000. Finally, Acrospire Investment Management LLC increased its stake in HCA Holdings by 14.3% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock valued at $140,000 after purchasing an additional 200 shares in the last quarter. Institutional investors and hedge funds own 73.77% of the company’s stock.

Shares of HCA Holdings (HCA) traded up 1.11% during trading on Friday, reaching $79.82. 1,656,462 shares of the company traded hands. The company has a 50 day moving average price of $78.65 and a 200 day moving average price of $83.57. The firm has a market capitalization of $28.83 billion, a price-to-earnings ratio of 10.70 and a beta of 0.67. HCA Holdings has a 12-month low of $67.00 and a 12-month high of $91.03.

HCA Holdings (NYSE:HCA) last posted its earnings results on Tuesday, July 25th. The company reported $1.75 EPS for the quarter, missing the consensus estimate of $1.80 by ($0.05). HCA Holdings had a negative return on equity of 48.08% and a net margin of 6.64%. The business had revenue of $10.73 billion for the quarter, compared to analyst estimates of $10.76 billion. During the same quarter in the prior year, the business earned $1.66 earnings per share. The firm’s quarterly revenue was up 4.0% on a year-over-year basis. On average, equities analysts predict that HCA Holdings will post $7.19 EPS for the current year.

HCA Holdings Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA Holdings (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.